Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Irritable Bowel Syndrome (IBS) Health Center

Font Size

Advisors Recommend Zelnorm for Constipation

But Expert Panel Would Limit Drug to Women Under Age 65
WebMD Health News

Editor's Note: In March 2007 the FDA asked Novartis -- the maker of Zelnorm -- to pull the drug from the market because of evidence that it raises the risk of heart attacks and stroke. But in July 2007 the FDA ruled that Zelnorm may be used by some patients in critical need of the drug who do not have heart problems.

July 15, 2004 -- An expert panel has backed expanded use of the anticonstipation drug Zelnorm. But they're calling for far tighter restrictions than its manufacturer had requested.

Advisors also voted for stricter safety warnings for existing uses of Zelnorm amid concerns that it can lead to a dangerous form of intestinal disease called ischemic colitis.

Advisors voted 10 to 3 to approve Zelnorm for the treatment for chronic constipation with no identifiable cause -- fewer than three bowel movements per week. But every expert voted for approval on the stipulation that the drug be used only in women and not in men or people aged 65 and over.

That was a far more restrictive approval than Novartis, the drug's manufacturer had sought. The company was asking FDA to approve Zelnorm to treat chronic constipation in men and women of all ages.

"This shouldn't be used in the elderly and that needs to be made loud and clear," says Brian L. Stom, MD, an epidemiologist from the University of Pennsylvania School of Medicine and a member of FDA's Gastrointestinal Drugs Advisory Committee.

The FDA usually follows the recommendations of its expert panels.

Safety Concerns

The drug was approved in August 2002 to treat women with constipation caused by irritable bowel syndrome. Until April, FDA had received 20 reports linking it to development of ischemic colitis, a dangerous disorder in which blood supply to the intestine is cut off or severely restricted. Thirteen of those cases required hospitalization and there was one death, FDA officials say.

The FDA has not established that Zelnorm directly caused the ischemic colitis cases, but officials note that many of the patients showed no signs or risk factors for the disease before taking the drug.

Today on WebMD

filling glass of water from faucet
Prevention strategies to try.
stomach ache
From symptoms to treatments.
Causes, symptoms, and treatments.
worried mature woman
Are they related?
IBS Trigger Foods
Supplements for IBS What Works
IBS Symptoms Quiz
digestive health
gluten free diet
digestive myths
what causes diarrhea
man with abdominal pain

WebMD Special Sections